Inventaire - your friends and communities are your best library

The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis

author

Tobias Derfuss

Jaume Sastre Garriga

Xavier Montalban

Laura Gaetano

Christian Wolf

Ludwig Kappos

1953 -

published in: Multiple sclerosis journal - experimental, translational and clinical

date of publication: 2020-01-01

main subject: relapsing-remitting multiple sclerosis

Cites articles 20

Date

Title

Authors

2017-02-20

Treatment optimization in multiple sclerosis: how do we apply emerging evidence?

Tjalf Ziemssen
2016-05-24

Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trials

Daniel Ontaneda
2016-05-04

Predictors of long-term disability accrual in relapse-onset multiple sclerosis

Dana Horáková, Thor Petersen, Helmut Butzkueven, Vilija Jokubaitis, Tomáš Kalinčík, Alessandra Lugaresi, Eva Havrdová, Eugenio Pucci, Maria Trojano, Pamela A. McCombe, Roberto Bergamaschi, Guillermo Izquierdo, Alexandre Prat, Pierre Duquette, Pierre Grammond, Patrizia Sola
2015-09-04

Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis

Philipp von Rosenstiel, Ludwig Kappos, Giancarlo Comi, Xavier Montalban
2015-03-20

Long-term effects of fingolimod in multiple sclerosis: the randomized FREEDOMS extension trial

Lixin Zhang-Auberson, Philipp von Rosenstiel, Ludwig Kappos, Krzysztof Selmaj, Ernst-Wilhelm Radue, Chris Polman, Reinhard Hohlfeld, Shannon Ritter
2014-03-28

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

Philipp von Rosenstiel, Ludwig Kappos, Peter Calabresi, Ernst-Wilhelm Radue, Tracy Stites, Kottil W Rammohan, Fred D. Lublin
2013-11-30

Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis

Xavier Montalban
2013-11-27

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects,World Medical Association Declaration of Helsinki
2012-03-01

Multiple sclerosis review
2011-12-21

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis

George C. Ebers, Anthony Traboulsee, Dawn Langdon, Christian Wolf
2010-06-19

Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial

Christian Wolf
2010-02-18

Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study.

Bianca Weinstock-Guttman
2010-03

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Jana Lízrová Preiningerová
2010-02-04

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

Hans-Peter Hartung, Ludwig Kappos, Frederik Barkhof, Giancarlo Comi, Guillermo Izquierdo, James Jin, Bhupendra O Khatri, Xavier Montalban, Tracy Stites
2010-02-04

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

Lixin Zhang-Auberson, Ludwig Kappos, Peter Calabresi, Frauke Zipp, Krzysztof Selmaj, Robert Weissert, Ernst-Wilhelm Radue, Chris Polman, Reinhard Hohlfeld
2009-12-22

Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results
2006-09-01

Oral fingolimod (FTY720) for relapsing multiple sclerosis

Ludwig Kappos, Giancarlo Comi, Chris Polman
2003-03-01

Can the Expanded Disability Status Scale be assessed by telephone?

Xavier Montalban, Mar Tintoré, Maria Pia Amato
2001-07

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis,Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis

Hans-Peter Hartung, Chris Polman
1996-04-01

Defining the clinical course of multiple sclerosis: Results of an international survey,Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis

Article - wd:Q91877226

Welcome to Inventaire

the library of your friends and communities

learn more